SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* ProQuest Investments IV, L.P. (Last) (First) (Middle) 2430 VANDERBILT BEACH ROAD, #108 - 190 (Street) NAPLES FL 34109 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 05/09/2017	3. Issuer Name and Ticker or Trading Symbol UroGen Pharma Ltd. [ URGN ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares, par value NIS 0.01 per share	1,451,329	D(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person* ProQuest Investments IV, L.P. (Last) (First) (Middle) 2430 VANDERBILT BEACH ROAD, #108 - 190 (Street) NAPLES FL 34109 (City) (State) (Zip)

1. Name and Address of Reporting Person* ProQuest Associates IV LLC (Last) (First) (Middle) 2430 VANDERBILT BEACH ROAD, #108 - 190 (Street) NAPLES FL 34109 (City) (State) (Zip)

1. Name and Address of Reporting Person* Moorin Jay (Last) (First) (Middle) C/O PROQUEST INVESTMENTS 2430 VANDERBILT BEACH ROAD, #108 - 190 (Street) NAPLES FL 34109 (City) (State) (Zip)

1. Name and Address of Reporting Person* SCHREIBER ALAIN (Last) (First) (Middle) C/O PROQUEST INVESTMENTS 2430 VANDERBILT BEACH ROAD, #108 - 190 (Street) NAPLES FL 34109 (City) (State) (Zip)

Explanation of Responses:

1. The securities are directly held by ProQuest Investments IV, L.P. and indirectly held by ProQuest Associates IV, LLC, the General Partner of ProQuest Investments IV, L.P. The individual managing members of ProQuest Associates IV, LLC are Jay Moorin and Alain Schreiber, M.D., who may be deemed to have shared voting and investment and dispositive power with respect to these shares. Each individual managing member disclaims beneficial ownership of these shares, except to the extent of their pecuniary interest in such shares.

Remarks:

	/s/ Pasquale DeAngelis	07/20/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

                                                                                       Exhibit 24.1



                                         POWER OF ATTORNEY



KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned hereby constitutes

and appoints, as of the date hereof, Pasquale DeAngelis, his or her true and lawful attorney-in-fact

with full power of substitution, resubstitution and revocation, for the undersigned and in the

undersigned's name, place and stead, in any and all capacities, including, but not limited to, the

undersigned's individual capacity, to execute all agreements, certificates, forms, instruments, or

other documents, and to take any action, necessary to file beneficial ownership reports on

Schedules 13D and 13G and Forms 3, 4 and 5 (including any amendments thereto, and including

any beneficial ownership reports which may in the future be required by the Securities and

Exchange Commission to be filed provided that the purpose and form of such reports is

substantially similar to Schedules 13D or 13G or Form 3, 4 or 5) under the Securities Exchange

Act of 1934 with the Securities and Exchange Commission or any stock exchange or similar

authority, in connection with any equity investments in Urogen Pharma Ltd. by each of the

undersigned in his or her individual capacity.



In connection with the appointment of such attorney-in-fact, each of the undersigned hereby

grants unto said attorney-in-fact full power and authority to do and perform each and every act

and thing which, in the opinion of such attorney-in-fact, may be requisite, necessary, proper or of

benefit to be done in and about the premises, as fully to all intents and purposes as the

undersigned might or could do in person, thereby ratifying and confirming all that said

attorney-in-fact (or attorney-in-fact's substitute or substitutes), may lawfully do or cause to be

done by virtue hereof, it being understood that the documents executed by such attorney-in-fact on

behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain

such terms and conditions as such attorney-in-fact may approve in his own discretion. Each of the

undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the

request of the undersigned, is not assuming any of the undersigneds' responsibilities to comply with

Section 13 or Section 16 of the Securities Exchange Act of 1934.



This Power of Attorney shall remain in full force and effect until each of the undersigned is no

longer required to file Forms 3, 4 and 5 or Schedules 13D or 13G with respect to the undersigned's

holdings of, and transactions in, securities issued by the Company, unless earlier revoked by the

undersigned in a signed writing delivered to the foregoing attorney-in-fact.







Dated:  July 20, 2017

                                                  /s/ Jay Moorin

                                                  ______________________________

                                                  Jay Moorin









                                                  /s/ Alain Schreiber

                                                  ______________________________

                                                  Alain Schreiber